Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-3.69%
$20.46
0% positive prob.
5-Day Prediction
-4.23%
$20.34
0% positive prob.
20-Day Prediction
-3.68%
$20.46
0% positive prob.
SEC 8-K filings with transcript text
Feb 23, 2026 · 100% conf.
1D
-3.69%
$20.46
5D
-4.23%
$20.34
20D
-3.68%
$20.46
hstm20251021_8k.htm
false 0001095565
0001095565
2025-12-31 2025-12-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 23, 2026 (February 23, 2026)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 23, 2026, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 23, 2026, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 23, 2026, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.035 per share of the Company’s outstanding common stock, which dividend will be payable on March 20, 2026 to holders of record on March 9, 2026.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 23, 2026
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Nov 3, 2025
hstm20250819_8k.htm
false 0001095565
0001095565
2025-11-03 2025-11-03
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3, 2025 (November 3, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On November 3, 2025 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On November 3, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on November 28, 2025 to holders of record on November 17, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: November 3, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Aug 4, 2025
hstm20250603_8k.htm
false 0001095565
0001095565
2025-08-04 2025-08-04
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2025 (August 4, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 4, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On August 4, 2025 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On August 4, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on August 29, 2025 to holders of record on August 18, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: August 4, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
This page provides HealthStream Inc. (HSTM) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on HSTM's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.